Narrow search
Showing 1 - 10 of 21,932
Cover Image
R&D competition and the direction of innovation
Bryan, Kevin A.; Lemus, Jorge A.; Marshall, Guillermo - In: International journal of industrial organization 82 (2022), pp. 1-15
Persistent link: https://www.econbiz.de/10013271953
Cover Image
Gruppenunterstützende Systeme in Forschung und Entwicklung : Anwendungspotentiale aus industrieller Sicht
Wohlenberg, Holger - 1994
Persistent link: https://www.econbiz.de/10000887908
Cover Image
Market size and pharmaceutical innovation
Dubois, Pierre; Mouzon, Olivier de; Scott-Morton, Fiopna; … - In: The Rand journal of economics 46 (2015) 4, pp. 844-871
Persistent link: https://www.econbiz.de/10011482294
Cover Image
Realoptionen als Controlling-Instrument : das Beispiel pharmazeutische Forschung und Entwicklung
Pritsch, Gunnar - 2000 - 1. Aufl.
Persistent link: https://www.econbiz.de/10001506460
Cover Image
Market size and pharmaceutical innovation
Dubois, Pierre; Mouzon, Oliver de; Scott Morton, Fiona; … - 2011
Persistent link: https://www.econbiz.de/10009012141
Cover Image
Market size and pharmaceutical innovation
Dubois, Pierre; Mouzon, Olivier de; Scott Morton, Fiona; … - 2011
Persistent link: https://www.econbiz.de/10009378418
Cover Image
F-&-E-Management in der Pharma-Industrie
Herzog, Richard (ed.); Brockhoff, Klaus (contributor) - 1995
Persistent link: https://www.econbiz.de/10013386696
Cover Image
How does basic research improve innovation performance in the world's major pharmaceutical firms?
Leten, Bart; Kelchtermans, Stijn; Belderbos, René - In: Industry and innovation 29 (2022) 3, pp. 396-424
Persistent link: https://www.econbiz.de/10013170079
Cover Image
Open innovation and intellectual property strategy : the catch-up processes of two Chinese pharmaceutical firms
Ren, Shengce; Su, Peiran - In: Technology analysis & strategic management 27 (2015) 10, pp. 1159-1175
Persistent link: https://www.econbiz.de/10011411855
Cover Image
Pharmaceutical research strategies
Phlippen, Sandra; Vermeersch, An - 2008
This study analyses 1400 research projects of the top 20 R&D-spending pharmaceuticals to identify the determinants of successful research projects. We provide clear evidence that externally sourced projects and projects involving biotechnologies perform better than internal projects and chemical...
Persistent link: https://www.econbiz.de/10011374419